Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Gastric Cancer Diagnostic Procedure Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?
The gastric cancer diagnostic procedure market size has demonstrated significant expansion in recent years. It is projected to increase from $1.54 billion in 2025 to $1.65 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.4%. The expansion observed in prior periods stems from factors such as the application of endoscopy in gastric diagnosis, the widespread adoption of biopsy procedures, the accessibility of imaging tests, the established hospital-based diagnostic infrastructure, and the growth of pathology labs.
The gastric cancer diagnostic procedure market size is projected to experience substantial growth in the coming years. It is anticipated to expand to $2.23 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.7%. This growth during the forecast period can be attributed to the advancements in liquid biopsy techniques, the broadening scope of molecular diagnostics, an increased demand for early detection, the integration of automation into diagnostic workflows, and the development of AI-enabled imaging analysis. Major trends observed in the forecast period include the increasing application of endoscopic diagnostic techniques, a rising adoption of molecular and genetic testing, a heightened need for early-stage cancer detection, the expansion of non-invasive diagnostic procedures, and the incorporation of advanced imaging technologies.
Get A Free Sample Report With In-Depth Market Insights:
Gastric Cancer Diagnostic Procedure Market Expansion Drivers: What’s Shaping Future Growth?
An increasing prevalence of smoking is projected to boost the gastric cancer diagnostic procedure market’s expansion in the future. Smoking involves the act of inhaling and exhaling smoke generated from burning tobacco or other substances. Gastric cancer diagnostic procedures hold significant importance for individuals with a history of smoking or those at risk of smoking-related cancers, as they facilitate early detection and identification of precancerous lesions, assist in developing personalized and tailored treatment plans, improve communication and coordination, and provide a comprehensive assessment of the gastric mucosa and surrounding tissues. For instance, in July 2023, a report from the World Health Organization, a Switzerland-based intergovernmental organization, indicated that more than 8 million people are killed by tobacco each year, including 1.3 million non-smokers who inhale second-hand smoke. Therefore, the rising surge in smoking is driving the growth of the gastric cancer diagnostic procedure market.
Gastric Cancer Diagnostic Procedure Market Segment Analysis And Revenue Potential
The gastric cancer diagnostic procedure market covered in this report is segmented –
1) By Procedure Type: Endoscopic Procedure, Biopsy, Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics, Immunoassays, Other Procedure Types
2) By Symptom Type: Symptomatic, Asymptomatic
3) By Offering Type: Instruments, Reagents And Consumables, Services
4) By Body Fluid Type: Blood, Urine, Saliva, Stomach Juice, Tissue, Other Body Fluid
5) By Disease Indication: Early Gastric Cancer, Advanced Gastric Cancer
Subsegments:
1) By Endoscopic Procedure: Upper Endoscopy (EGD), Endoscopic Ultrasound (EUS)
2) By Biopsy: Endoscopic Biopsy, Fine Needle Aspiration (FNA) Biopsy
3) By Tissue Tests: Histopathology, Immunohistochemistry
4) By Lab Tests: Blood Tests, Tumor Markers
5) By In-Vitro Diagnostic Tests: Genetic Testing, Molecular Profiling
6) By Imaging Tests: Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) Scan
7) By Molecular Diagnostics: PCR Testing, Next-Generation Sequencing (NGS)
8) By Multiplexing Molecular Diagnostics: Multiplex PCR, Microarray Analysis
9) By Immunoassays: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA)
10) By Other Procedure Types: Breath Tests, Liquid Biopsies
Gastric Cancer Diagnostic Procedure Market Industry Trends Fueling Future Revenue Growth
Leading companies in the gastric cancer diagnostic procedure market are concentrating on technological enhancements, including dual cell-free and exosomal miRNA liquid biopsy assays, to achieve a competitive advantage. These assays quantify minute noncoding RNAs found freely in the bloodstream and encased within tumor-derived exosomes, allowing for exceptionally sensitive and specific detection of gastric cancer from a simple blood sample. For example, in December 2024, Cizzle Bio, a U.S.-based biotechnology firm, unveiled its DEX G2 blood test. This test integrates cell-free and exosomal miRNAs to attain roughly 95% sensitivity and 97% specificity, requiring only a standard blood draw instead of an invasive endoscopy. This innovation holds the potential for earlier diagnosis and expanded screening access, though its widespread acceptance might face limitations from regulatory approval schedules and the need for real-world validation.
Gastric Cancer Diagnostic Procedure Market Key Players Shaping Industry Direction
Major companies operating in the gastric cancer diagnostic procedure market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Myriad Genetics Inc., Foundation Medicine Inc., Biocept Inc., Illumina Inc., Roche Diagnostics, QIAGEN N V, Bio-Rad Laboratories Inc., Siemens Healthineers, Danaher Corporation, Becton Dickinson, bioMérieux SA, PerkinElmer Inc., NeoGenomics Laboratories, Guardant Health Inc., Natera Inc., Caris Molecular Diagnostics, Adaptive Biotechnologies Corp, 10x Genomics Inc
View The Full Gastric Cancer Diagnostic Procedure Market Report:
Gastric Cancer Diagnostic Procedure Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the gastric cancer diagnostics procedure market in 2025. The regions covered in the gastric cancer diagnostic procedure market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
